Lifecore Biomedical, Inc.

US$6.36As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LFCRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (7.06%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.97
PE TTM —
TSR TTM (11.54%)
Mkt cap US$241.1M
ROIC (3.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.97
9.54%
(96.76%)
Hold 11|7|9|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.10
0.11
0.11
7.80%
9.80%
23.68%
18.45%
Revenue$M
15.38
15.13
15.31
15.02
12.62%
6.39%
4.71%
1.89%
Peers (US$241.1M)
Cap (US$)
PE
245.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.650
0.821
0.613
EBIT/Intx
0.298
0.874
0.782
Own earn%
(105.70)
26.37
23.52
Sh yield%
40.28
35.23
32.69
Owners
Insiders/Inst%
1.07
89.24
Short interest%
2.45
SBC / revenue%
1.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
9–14
$1 testx
0.1
Incr. ROIC%
5